TABLE 11.
Results for neurodevelopment in included studies evaluating infants fed formulas containing palm oil or palm olein and sn-2 palmitate
Ages and Stages Questionnaire, Third Edition (ASQ-3) | |||
---|---|---|---|
Reference | Time point(s) | Groups | Outcome |
Wu et al., 2021 (63) | T1: 16 weeks T2: 24 weeks | SN21 (46.3%) + GOVO1 (10.3%) + GOHM | T1: 5 Developmental Domain Median Unadjusted Scores (communication, gross motor, fine motor, problem-solving, personal, and social): No differences between groups T2: 5 Developmental Domain Median Unadjusted Scores (communication, gross motor, fine motor, problem-solving, personal, and social): No differences between groups |
% Indicates the percentage of palmitic acid esterified at the sn-2 position in formula. Abbreviations: ARA, arachidonic acid; GO, galacto-oligosaccharides; HM, human milk; sn, stereospecific numbered; SN2, stereospecific numbered–2 palmitate; T1, time point 1; T2, time point 2; VO, vegetable oil.
Indicates the addition of long-chain PUFAs, including 22:6n-3 (DHA) and 20:4n-6 (ARA).